This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Celator Pharmaceuticals, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Ronald Cheung
Introduction
Ronald Cheung is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of hematology through his innovative approaches to treatment. His work focuses on providing alternatives for patients who are ineligible for standard intensive chemotherapy.
Latest Patents
Ronald Cheung holds a patent for a method titled "Low-intensity treatment of hematological disorders." This invention relates to compositions and methods for treating patients with hematological proliferative disorders using low-intensity treatment with CPX-351, a liposomal composition of daunorubicin and cytarabine. This patent represents a significant advancement in the treatment options available for patients facing these challenging conditions. He has 1 patent to his name.
Career Highlights
Cheung is associated with Celator Pharmaceuticals, Inc., where he has been instrumental in developing innovative therapies. His work has been pivotal in advancing treatment methodologies that cater to patients with specific needs in hematology.
Collaborations
Throughout his career, Ronald Cheung has collaborated with esteemed colleagues such as Stefan Faderl and Qi Wang. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
Ronald Cheung's contributions to the field of hematology through his innovative patent and collaborations highlight his commitment to improving patient care. His work continues to pave the way for advancements in treatment options for hematological disorders.